I think it’s a reasonable concern, especially for AI and bio, and I guess that is part of what a grantmaker might investigate. Any such negative effect could be offset by: (1) associating scientific quality with EA/ recruiting competent scientists into EA, (2) improving the quality of risk-reducing research, and (3) improving commentary/reflection on science (which could help with identifying risky research). My instinct is that (1-3) are greater than risk-increasing effects, at least for many projects in this space and that most relevant experts would think so, but it would be worth asking around.
I think it’s a reasonable concern, especially for AI and bio, and I guess that is part of what a grantmaker might investigate. Any such negative effect could be offset by: (1) associating scientific quality with EA/ recruiting competent scientists into EA, (2) improving the quality of risk-reducing research, and (3) improving commentary/reflection on science (which could help with identifying risky research). My instinct is that (1-3) are greater than risk-increasing effects, at least for many projects in this space and that most relevant experts would think so, but it would be worth asking around.